Utama › Kanser Ovari › California › Mountain View
Kajian klinikal Kanser Ovari di Mountain View, CA
19 kajian untuk Kanser Ovari sedang mencari peserta di lokasi dalam dan sekitar Mountain View (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Mengambil pesertaFasa 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauh
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Stanford University School of Medicine, Palo Alto · 5 mi jauh
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Stanford University, Palo Alto · 5 mi jauh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Mengambil pesertaFasa 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- Stanford University Medical Center, Stanford · 5 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
Mengambil pesertaFasa 1
- Stanford University, Palo Alto · 5 mi jauh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Stanford, Palo Alto · 5 mi jauh
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauh
- dan 1 lagi
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 150, Palo Alto · 5 mi jauh
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation, Palo Alto · 5 mi jauh
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Stanford University, Stanford · 5 mi jauh
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Mengambil pesertaFasa 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Mengambil pesertaKajian pemerhatian
- Stanford University School of Medicine, Stanford · 5 mi jauh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Mengambil pesertaFasa 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · 5 mi jauh
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
- Stanford Hospital, Palo Alto · 5 mi jauh
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Mengambil pesertaFasa 2
- Stanford Cancer Center, Palo Alto · 5 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauh
Kajian Kanser Ovari di bandar lain
- Houston, TX89 kajian
- New York City, NY69 kajian
- Boston, MA61 kajian
- Los Angeles, CA50 kajian
- Nashville, TN49 kajian
- Arlington, VA46 kajian
- Philadelphia, PA44 kajian
- Columbus, OH39 kajian
- St. Louis, MO38 kajian
- Chicago, IL36 kajian
- San Antonio, TX31 kajian
- Cleveland, OH30 kajian
Kajian lain di Mountain View
- Kanser (semua jenis)40 kajian
- Kanser Payudara26 kajian
- Kanser Metastatik25 kajian
- Kanser Paru-paru Bukan Sel Kecil21 kajian
- Leukemia Mieloid Akut19 kajian
- Gangguan Spektrum Autisme17 kajian
- Kanser Paru-paru17 kajian
- Kanser Prostat15 kajian
- Kegagalan Jantung15 kajian
- Autisme13 kajian
- Leukemia Limfoblastik Akut13 kajian
- Kanser Kolorektal13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.